PREVIOUS WEBINARS: |
||
| Month | Webinar Topic | Presenter(s) |
| January 2020 | Predictors of availability of long-acting medication for opioid use disorder | Dr. Chelsea Leigh Shover |
|
February 2020 |
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl | Dr. Shannon Miller and Sydney Silverstein, PhD |
| May 20, 2020 |
The conundrum of long term opioids for pain: Darned if you do, darned if you don’t” |
Dr. Ajay Manhapra |
| May 27, 2020 |
Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of MAT for veterans with OUD in low-performing facilities |
Hildi Hagedorn PhD |
| June 24, 2020 |
‘Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting’ |
Dr. Joao P De Aquino Lima |
| July 15, 2020 |
Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems |
Dr. A J Saxon |
| July 22, 2020 |
Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose |
Dr. Utibe Essien |
| August 19, 2020 |
“Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs” |
Dr. Andrea K. Finlay |
| August 26, 2020 |
Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study |
Dr. Corey Hayes |
| Sept. 23, 2020 |
‘A computerized anxiety sensitivity intervention for opioid use disorders: A pilot investigation among veterans’ |
Amanda M. Raines PhD |
| October 21, 2020 |
Treating Alcohol Use Disorder in the U.S. Veterans: The Role of Traumatic Brain Injury |
Dr. Ricardo Jorge |
| October 28, 2020 |
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report. |
Dr. G Bart and Dr. Andrew Saxon |
